Related Experiment Video
Updated: May 19, 2026

08:58
Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
Optofluidic device for label-free cell classification from whole blood
Tsung-Feng Wu1, Zhe Mei2,3, Yu-Hwa Lo1,3
1Materials Science Program, University of California at San Diego, La Jolla, California 92093-0418, USA. tsungfong@gmail.com.
Lab on a Chip
|August 10, 2012
Summary
This study presents a novel optofluidic lab-on-a-chip device for cell analysis. The device efficiently classifies cells by size and stiffness, enabling neutrophil detection in whole blood for potential point-of-care diagnostics.
Area of Science:
- Optofluidics
- Biomedical Engineering
- Cellular Analysis
Background:
- Accurate cell classification is crucial for disease diagnosis.
- Existing methods for cell analysis can be complex and time-consuming.
- Neutrophil count is a key indicator of immune status, especially in cancer patients.
Purpose of the Study:
- To develop and demonstrate a novel optofluidic lab-on-a-chip device for cell classification.
- To show the device's capability in distinguishing cells based on size and stiffness.
- To validate the device for neutrophil detection and counting in whole human blood.
Main Methods:
- Utilized an optofluidic lab-on-a-chip device measuring optically encoded forward scattering signals.
- Analyzed cell position, velocity, and generated 2-D cell distribution plots.
- Applied the method to live/fixed HeLa cells and whole human blood samples with minimal preparation.
Main Results:
- Demonstrated cell classification based on size and stiffness.
- Successfully detected neutrophils from other white blood cells.
- Quantified neutrophil counts in whole human blood with a simplified process.
Conclusions:
- The developed optofluidic device offers a simple, inexpensive method for cell classification by size and stiffness.
- The system shows promise for point-of-care and home-care neutrophil monitoring.
- This technology could aid in assessing immune function for cancer patients undergoing chemotherapy.

